Doseology Appoints Maryam Marissen as CEO to Prepare for Next Growth Stage Read More » January 13, 2022
Doseology Completes Development and Test Marketing of Adaptogenic Mushroom Product Line Read More » January 6, 2022
Doseology Prepares to Expand Mushroom Production by Hiring Dr. Wellman-Labadie to Oversee Planned Research and Development Laboratory Read More » December 15, 2021
Doseology Receives Receipt for Final Prospectus and Amounts Listing on the CSE : MOOD Read More » December 12, 2021
Doseology Prepares for Growth Phase in Psychedelic-Focused Mental Health Market, Completes Dealer’s License Application Read More » December 6, 2021
Doseology Receives Receipt for Final Prospectus and Announces Listing on the CSE Read More » November 12, 2021
